Prostate Cancer - Results from #20960

Intensity modulated radiotherapy (IMRT) to prostate and pelvic nodes; is pelvic lymph node coverage adequate with fiducial-based image guided radiotherapy? - Abstract April 23, 2014

Docetaxel based chemotherapy in the treatment of patients with castration resistant prostate cancer - Abstract April 23, 2014

Bilaterally positive biopsy cores are associated with non-organ-confined disease in prostate cancer patients eligible for active surveillance - Abstract April 23, 2014

Evaluation of 3 T pelvic MRI imaging in prostate cancer patients receiving post-prostatectomy IMRT - Abstract April 22, 2014

The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancer - Abstract April 22, 2014

Nonmetastatic castration-resistant prostate cancer - Abstract April 22, 2014

Early experience with active surveillance in low-risk prostate cancer treated - Abstract April 22, 2014

Prevalence of lymph node metastasis in radical prostatectomy; a retrospective and multicenter study in Iran - Abstract April 22, 2014

Monitoring of health-related quality of life and symptoms in prostate cancer survivors: A randomized trial - Abstract April 22, 2014

Prostate cancer and its mimics at multiparametric prostate MRI - Abstract April 22, 2014

Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline - Abstract April 22, 2014

Targeted focal therapy in the management of organ-confined prostate cancer - Abstract April 22, 2014

Relative value of race, family history and prostate-specific antigen as indications for early initiation of prostate cancer screening - Abstract April 22, 2014

Diffusion-weighted magnetic resonance imaging detects significant prostate cancer with a high probability: Results of a prospective study with final pathology of prostates with and without cancer as the reference standard - Abstract April 22, 2014

Transperineal versus transrectal prostate biopsy for predicting the final laterality of prostate cancer: Are they reliable enough to select patients for focal therapy? Results from a multicenter international study - Abstract April 21, 2014

A review of continuous vs intermittent androgen deprivation therapy: Redefining the gold standard in the treatment of advanced prostate cancer. Myths, facts and new data on a ″perpetual dispute″ - Abstract April 21, 2014

Management of men with a suspicion of prostate cancer after negative initial prostate biopsy results - Abstract April 21, 2014

Psychosocial longitudinal study profile and distress of couples in relation to the conduct of prostate biopsy - Abstract April 21, 2014

Screening for prostate cancer with the prostate-specific antigen test: A review of current evidence - Abstract April 21, 2014

Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy - Abstract April 21, 2014

Page 1049 of 1447